Abang, Zamiah .
HRN: 24-82-27 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/18/2024
CEFUROXIME 500MG (TAB)
03/18/2024
03/24/2024
ORAL
500mg
BID
Sp RMLE With Repair
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes